Rosuvastatin use increases plasma fibrinolytic potential: a randomised clinical trial

We conducted a study to assess the effect of rosuvastatin use on fibrinolysis in patients with previous venous thromboembolism (VTE). This was a post hoc analysis within the STAtins Reduce Thrombophilia (START) study (NCT01613794). Plasma fibrinolytic potential, fibrinogen, plasmin inhibitor, plasmi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Br J Haematol
Egile Nagusiak: Schol‐Gelok, Suzanne, de Maat, Moniek P. M., Biedermann, Joseph S., van Gelder, Teun, Leebeek, Frank W. G., Lijfering, Willem M., van der Meer, Felix J. M., Rijken, Dingeman C., Versmissen, Jorie, Kruip, Marieke J. H. A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2020
Gaiak:
Platelets Haemostasis and Thrombosis
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7539918/
https://ncbi.nlm.nih.gov/pubmed/32301122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.16648
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak